Drugs / Laninamivir Octanoate
Laninamivir Octanoate
Trials 6 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT02022761 | Oct 2013 | asthma | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
| Phase 1 | NCT00995826 | Apr → Sep 2009 | influenza | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
| Phase 1 | NCT00657111 | Apr 2008 → Oct 2009 | influenza | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
| Phase 1 | NCT00311714 | Apr → Dec 2007 | influenza | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT02014649 | Nov 2013 → Apr 2014 | influenza | Biota Scientific Management Pty Ltd | Terminated | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00803595 | Nov 2008 → Mar 2009 | influenza | Daiichi Sankyo | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01793883 Comparator | May 2013 → May 2014 | influenza | Biota Scientific Management Pty Ltd | Completed | No outcome recorded |
Press releases naming this drug 5 releases
| Date | Issuer | Release |
|---|---|---|
| 2010-02-01 | Daiichi Sankyo | Daiichi Sankyo Submits a New Drug Application in Japan for CS-8958, a Long-Acting Neuraminidase Inhibitor for the Treatment of Influenza daiichisankyo.com ↗ |
| 2009-11-05 | Daiichi Sankyo | Daiichi Sankyo Launches New Phase 3 Trial with CS-8958 for Flu Prevention daiichisankyo.com ↗ |
| 2009-08-10 | Daiichi Sankyo | Positive top line results from Phase III study (MARVEL) of anti-influenza virus agent 'CS-8958' daiichisankyo.com ↗ |
| 2008-11-17 | Daiichi Sankyo | Start of Phase III Trial on the Anti-influenza Drug CS-8958 daiichisankyo.com ↗ |
| 2007-04-18 | Daiichi Sankyo | Completion of Phase I Trial on the Anti-influenza Drug CS-8958 daiichisankyo.com ↗ |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Laninamivir octanoate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02022761 ↗ |
| Known as | CS-8958 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995826 ↗ |
| Known as | Laninamivir octanoic acid ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL467058 ↗ |
| Known as | R-118958 | ChEMBL registry synonym — accepted as the source's own label CHEMBL467058 ↗ |
| Modality | Small molecule | — CHEMBL467058 ↗ |
| Route | Inhaled | “single dose administered via inhalation” NCT00657111 ↗ |